Humana (HUM)

Humana Inc. [NYSE: HUM] announced today its latest collaboration with healthcare software company Epic, becoming the first health insurer to integrate health plan information directly into the MyChart accounts patients may already use with their healthcare providers.

Leading health services company Humana Inc. (NYSE: HUM) is launching the inaugural Humana Cognitive GamesTM today to encourage older adults to exercise their minds and play an active role in maintaining their brain health.

Humana will release its 2Q25 financial results, as well as prepared management remarks (in PDF format), at 6:00 a.m. Eastern time on July 30, 2025. The company will host a live question-and-answer session at 8:00 a.m. Eastern time that morning to discuss its financial results for the quarter and earnings guidance for 2025.

The Humana Foundation, philanthropic arm of Humana Inc. (NYSE: HUM), announced today a $500,000 donation to aid recovery efforts in Central Texas following the tragic flooding that struck over the July 4 holiday weekend. The Humana Foundation is coordinating efforts with its partner in the region, Reach Resilience, and is matching their donation of $500,000.

Humana Healthy Horizons is now a Medicaid plan option for Virginians covered by Virginia Cardinal Care.

The Trust for the National Mall, Humana (NYSE: HUM), and the Humana Foundation announced today that the highly-anticipated National Mall of Pickleball is returning to America’s Front Yard, the National Mall, for a third year.

Humana Inc. (NYSE: HUM), one of the nation’s leading health and well-being companies, today announced the expansion of its validated science-based target (SBT) with recent approval of a new financial institution target by the Science Based Targets initiative (SBTi). This milestone highlights Humana’s dedication to sustainability, reinforcing its commitment to improving health and well-being while aiming for significant emissions reductions across the company's value chain.

Americans are signaling a shift in what it means to live a fulfilling life, with many preferring independence over longevity without self-sufficiency. While seniors, in particular, maintain an optimistic outlook on aging, they face significant challenges as they grow older, including financial strain, anxiety about future mental health and persistent negative cultural attitudes toward aging.

Humana Inc. (NYSE: HUM), a leading health and well-being company, is expanding its commitment to senior wellness with the launch of Invite, a new campaign designed to encourage older adults of all fitness levels to stay active, connected and engaged – starting with the fastest-growing sport in America: pickleball.

As the presenting sponsor of the 2025 National Senior Games, leading health and well-being company Humana Inc. (NYSE: HUM) today announced the 2025 Humana Game Changers – a group of 10 remarkable athletes who exemplify healthy aging, resilience and the power of staying active in both body and mind.

NEW YORK, June 06, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Humana Inc.  (“Humana” or the “Company”) (NYSE: HUM).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

NEW YORK, June 02, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Humana Inc.  (“Humana” or the “Company”) (NYSE: HUM).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

NEW YORK, May 28, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Humana Inc.  (“Humana” or the “Company”) (NYSE: HUM).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

The Humana Foundation, philanthropic arm of Humana Inc. (NYSE: HUM), announced today a $50,000 contribution to advance sustained recovery efforts in Kentucky communities devastated by the most recent wave of severe storms and tornadoes.

NEW YORK, May 22, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Humana Inc.  (“Humana” or the “Company”) (NYSE: HUM).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

The Humana Foundation, the philanthropic arm of Humana Inc. for the past 44 years, is proud to announce that Tiffany Benjamin, the foundation’s CEO, has been named to the inaugural TIME100 Philanthropy list, celebrating the singular figures shaping the future of giving.

NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Humana Inc. (“Humana” or the “Company”) (NYSE: HUM). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

A team of experienced mental health professionals has launched Tulsa Metro Psychiatry (918-982-6524), a full-service practice offering diagnostic evaluations, medication management, and counseling services for patients across all age groups.

Empire Psychiatry, a fast-rising name in the world of mental wellness, is proud to announce its launch as New York’s go-to destination for thoughtful, personalized psychiatric care. With a commitment to making mental health services more accessible, human-centered, and stigma-free, Empire Psychiatry is already making waves among patients and practitioners alike.

NEW YORK, May 13, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Humana Inc. (“Humana” or the “Company”) (NYSE: HUM). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

CenterWell Specialty Pharmacy has once again received the MMIT Specialty Pharmacy Patient Choice Award in the PBM/Payer category, its seventh such win in the past eight years. The award recognizes best-in-class customer satisfaction and commitment to patient care by a specialty pharmacy.

NEW YORK, May 09, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Humana Inc.  (“Humana” or the “Company”) (NYSE: HUM).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

NEW YORK, May 05, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Humana Inc. (“Humana” or the “Company”) (NYSE: HUM). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

Humana Inc. (NYSE: HUM) today reported consolidated pretax results and net earnings per share (EPS) for the quarter ended March 31, 2025 (1Q25) versus the quarter ended March 31, 2024 (1Q24) as noted in the tables below.

Humana Inc. (NYSE: HUM) announced today that its Board of Directors has declared a cash dividend to stockholders of $0.885 per share payable on July 25, 2025 to stockholders of record as of the close of business on June 27, 2025.